Your Health, We Care
Lucius Pharmaceuticals has always been committed to scientific research and innovation and constantly explores new boundaries in medication research and development. We bring together a first-class scientific team to conduct medication screening and optimization through advanced technology platforms. Through in-depth research and innovative ideas, we will promote new breakthroughs in medicine.
Lucius Pharmaceutical's scientific research results not only bring more effective treatment options to patients but also inject new vitality into the development of the industry. We firmly believe that continuous scientific research and innovation is the core driving force for enterprise development and the key to serving human health.
In strict compliance with EU pharmaceutical standards, Lucius Pharmaceuticals has introduced a series of advanced specialized pharmaceutical equipment for the production of various medications, including Anti-tumor, Antiviral, Biologics, Cephalosporins, and commonly used medications.
The R&D team of Lucius Pharmaceuticals is a professional, efficient, and innovative scientific research team. Bringing together top experts in the field of pharmaceuticals, we are committed to the research and development and breakthrough of new medications. Guided by the needs of patients, the team is constantly exploring new treatments in order to achieve more breakthroughs in the field of global pharmaceuticals.
Lucius Pharmaceutical follows the principles of cutting-edge science and technology, utilizing industry-leading pharmaceutical equipment. This advanced equipment not only boasts high levels of automation and intelligence but also ensures the accuracy and efficiency of medicine production. Every step of the production process, from raw material screening to finished product packaging, is strictly monitored and controlled.
Standard system FDA Current Production Specifications:60
Dosage Forms freeze-dried injections, injections, oral tablets and capsules, etc.
Standard system European GMP, British MHRA Current Production Specifications:100
Dosage Forms Tablets, Capsules, Dry Syrups, In-Capsule Medications.
Standard system WHO GMP Current Production Specifications: 20
Dosage Forms Syrups, Suspensions, Antacid Suspensions, Liquid-Filled Gelatin Capsules.
Standard system WHO GMP Current Production Specifications: 25
Dosage Forms Lyophilized injections, Syrup, High-dose injections, Fat emulsion (nutrient) injections, Pre-filled syringes.
Standard system US FDA Current Product Count: 60
Dosage Forms lyophilized injections, injections, cytotoxic drugs, oral tablets and capsules, etc.
Standard system European GMP, WHO GMP
Dosage Forms tablets, capsules, dry powder injections, lyophilized injections.
Lucius Pharmaceuticals follows international standards for quality management systems and considers the health and safety of patients as its top priority. We have implemented a thorough quality management system that involves rigorous monitoring and testing at every stage, from raw material procurement to production, storage, and sales. By continuously improving quality and innovating technologically, we ensure that every medication meets the highest standards of quality. Lucius Pharmaceuticals is committed to being your trusted guardian of your health.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
